✦ LIBER ✦

9080 Phase I trial of gemcitabine/carboplatin(GC), followed by pemetrexed/gemcitabine (PG) in chemonaïve patients (pts) with advanced NSCLC

✍ Scribed by Steele, J.; Patel, G.; Klabatsa, A.; Das, M.; Kalidas, B.; Nicoll, C.; Wells, P.; Fennell, D.; Fennell, D.A.; Rudd, R.M.

Book ID: 122083257
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71793-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P382 A randomized phase II trial of sequ

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)

✍ Teodorescu, G.; Ciuleanu, T.; Grigorescu, A.; Firoiu, E.; Ruta Muresan, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Final results of a phase II trial of fir

Final results of a phase II trial of first-time therapy with gemcitabine (Gemtro®) (G) and carboplatin (C) in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Jovtis, S; Brocato, N; Temperley, G; Balbiani, L; Comba, A.Z; Rondinon, M; Almir 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

P-531 Phase II study of sequential gemci

P-531 Phase II study of sequential gemcitabine (G) and carboplatin (C) followed by docetaxel (D) as first line chemotherapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Chiappori, Alberto; Simon, George; Lima, Caio Rocha; Williams, Charles; Haura, E 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Phase II trial of dose-dense doxorubicin

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function

✍ Matthew D. Galsky; Alexia Iasonos; Svetlana Mironov; Joseph Scattergood; Mary G. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

9096 POSTER EGFR-targeting Chimeric Mono

9096 POSTER EGFR-targeting Chimeric Monoclonal lgG-1 Antibody Cetuximab in a Phase ll/lll Study Added Either to Gemcitabine Followed by Docetaxel or Carboplatin Plus Gemcitabine for Chemonaive Patients With Advanced Non-small Cell Lung Cancer (NSCLC) – Results of the Phase II Study Part

✍ Kortsik, C.; Schmid-Bindert, G.; Pilz, L.R.; Cicenas, S.; Eschbach, C.; Kollmeie 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

1231 A phase I study of axitinib (AG-013

1231 A phase I study of axitinib (AG-013736) combined with paclitaxel/carboplatin (P/C), gemcitabine/cisplatin (Gem/Cis) or pemetrexed/cisplatin (Pem/Cis) in patients (pts) with solid tumours, including advanced non-small cell lung cancer (NSCLC)

✍ M.F. Kozloff; L.P. Martin; M. Krzakowski; T.A. Samuel; J. Tarazi; B. Rosbrook; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB